1 | aggregation | 2,774 |
2 | coordination | 1,558 |
3 | aggregates | 793 |
4 | symmetry | 572 |
5 | asymmetry | 555 |
6 | gating | 351 |
7 | elastase | 253 |
8 | engraftment | 219 |
9 | hysteresis | 146 |
10 | footprint | 94 |
11 | hyperphosphorylation | 72 |
12 | co-ordination | 51 |
13 | aggregability | 47 |
14 | amastigotes | 42 |
15 | steadiness | 40 |
16 | h-bond | 39 |
17 | aqueduct | 34 |
18 | homodimers | 32 |
19 | incoordination | 32 |
20 | cocontraction | 23 |
21 | cross-matching | 17 |
22 | symmetries | 17 |
23 | clumps | 16 |
24 | nanogels | 14 |
25 | 12-lipoxygenase | 9 |
26 | pgf1alpha | 9 |
27 | gp5 | 8 |
28 | homozygosis | 7 |
29 | rotamer | 7 |
30 | self-assemblies | 7 |
31 | 15g | 6 |
32 | copigmentation | 6 |
33 | gplb | 6 |
34 | hyper-aggregability | 6 |
35 | ns4b | 6 |
36 | rosettes | 6 |
37 | self-oscillation | 6 |
38 | chlorophenol | 5 |
39 | tb16.3-echa1 | 5 |
40 | antiaggregants | 4 |
41 | at-076 | 4 |
42 | hyperaggregability | 4 |
43 | angiopep-peg-pla | 3 |
44 | glycogenic | 3 |
45 | macrophage-csf | 3 |
46 | microbialites | 3 |
47 | rmdsod2 | 3 |
48 | st-eepscs | 3 |
49 | 3-acetyl-4-hydroxy-6-alkyl-α-pyrone | 2 |
50 | activity/function | 2 |
51 | anti-aggregants | 2 |
52 | diet.the | 2 |
53 | glycal | 2 |
54 | heterotrimers | 2 |
55 | phosphorelays | 2 |
56 | phosphorylation/dephosphorylation | 2 |
57 | rainier | 2 |
58 | 'paralysis | 1 |
59 | 143-3beta | 1 |
60 | 198,000/µl | 1 |
61 | 2,3-disubstituted-cis-2,3-dihydrobenzofurans | 1 |
62 | 2,4,6-trihydroxymandelate | 1 |
63 | 3-acetyl-4-hydroxy-6-propyl-α-pyrone | 1 |
64 | 3-chloro-5-nitrotyrosine | 1 |
65 | 6,284,262 | 1 |
66 | abi/pwv | 1 |
67 | acam2017 | 1 |
68 | activability | 1 |
69 | activatability | 1 |
70 | activation/thrombocytopenia | 1 |
71 | adhesion/activation | 1 |
72 | adp-receptors | 1 |
73 | aggregation- | 1 |
74 | aggregation-inhibiting | 1 |
75 | aggregation/activation | 1 |
76 | aureolysin | 1 |
77 | azurophil | 1 |
78 | bicep2 | 1 |
79 | cd4ol | 1 |
80 | coherencies | 1 |
81 | condi- | 1 |
82 | d4-2 | 1 |
83 | deaggregation | 1 |
84 | demargination | 1 |
85 | dihydropyrazinones | 1 |
86 | dp47 | 1 |
87 | elastase-generated | 1 |
88 | engrafments | 1 |
89 | fat/muscle | 1 |
90 | function.evidence | 1 |
91 | gaasxsb1-x | 1 |
92 | h2map | 1 |
93 | hemiacetals | 1 |
94 | his6-mm1854 | 1 |
95 | hydroxycyclopentadiene | 1 |
96 | isolate-dextran | 1 |
97 | jealousies | 1 |
98 | k5fluo-3 | 1 |
99 | l1-solver | 1 |
100 | mercaptoacetaldehyde | 1 |
101 | microcavitations | 1 |
102 | myosin-polysaccharide | 1 |
103 | parameters/activation | 1 |
104 | phagocytosis/oxidative | 1 |
105 | poly-chains | 1 |
106 | royally | 1 |
107 | ta-vacancy | 1 |
108 | triacetyl-d-mannosan | 1 |
109 | trialtypes | 1 |
110 | urinocoltures | 1 |
111 | v1-ige | 1 |
112 | á-granule | 1 |
113 | β-1,3-xylobiose | 1 |
1 | 'paralysis | 1 |
2 | 12-lipoxygenase | 9 |
3 | 143-3beta | 1 |
4 | 15g | 6 |
5 | 198,000/µl | 1 |
6 | 2,3-disubstituted-cis-2,3-dihydrobenzofurans | 1 |
7 | 2,4,6-trihydroxymandelate | 1 |
8 | 3-acetyl-4-hydroxy-6-alkyl-α-pyrone | 2 |
9 | 3-acetyl-4-hydroxy-6-propyl-α-pyrone | 1 |
10 | 3-chloro-5-nitrotyrosine | 1 |
11 | 6,284,262 | 1 |
12 | abi/pwv | 1 |
13 | acam2017 | 1 |
14 | activability | 1 |
15 | activatability | 1 |
16 | activation/thrombocytopenia | 1 |
17 | activity/function | 2 |
18 | adhesion/activation | 1 |
19 | adp-receptors | 1 |
20 | aggregability | 47 |
21 | aggregates | 793 |
22 | aggregation | 2,774 |
23 | aggregation- | 1 |
24 | aggregation-inhibiting | 1 |
25 | aggregation/activation | 1 |
26 | amastigotes | 42 |
27 | angiopep-peg-pla | 3 |
28 | anti-aggregants | 2 |
29 | antiaggregants | 4 |
30 | aqueduct | 34 |
31 | asymmetry | 555 |
32 | at-076 | 4 |
33 | aureolysin | 1 |
34 | azurophil | 1 |
35 | bicep2 | 1 |
36 | cd4ol | 1 |
37 | chlorophenol | 5 |
38 | clumps | 16 |
39 | co-ordination | 51 |
40 | cocontraction | 23 |
41 | coherencies | 1 |
42 | condi- | 1 |
43 | coordination | 1,558 |
44 | copigmentation | 6 |
45 | cross-matching | 17 |
46 | d4-2 | 1 |
47 | deaggregation | 1 |
48 | demargination | 1 |
49 | diet.the | 2 |
50 | dihydropyrazinones | 1 |
51 | dp47 | 1 |
52 | elastase | 253 |
53 | elastase-generated | 1 |
54 | engrafments | 1 |
55 | engraftment | 219 |
56 | fat/muscle | 1 |
57 | footprint | 94 |
58 | function.evidence | 1 |
59 | gaasxsb1-x | 1 |
60 | gating | 351 |
61 | glycal | 2 |
62 | glycogenic | 3 |
63 | gp5 | 8 |
64 | gplb | 6 |
65 | h-bond | 39 |
66 | h2map | 1 |
67 | hemiacetals | 1 |
68 | heterotrimers | 2 |
69 | his6-mm1854 | 1 |
70 | homodimers | 32 |
71 | homozygosis | 7 |
72 | hydroxycyclopentadiene | 1 |
73 | hyper-aggregability | 6 |
74 | hyperaggregability | 4 |
75 | hyperphosphorylation | 72 |
76 | hysteresis | 146 |
77 | incoordination | 32 |
78 | isolate-dextran | 1 |
79 | jealousies | 1 |
80 | k5fluo-3 | 1 |
81 | l1-solver | 1 |
82 | macrophage-csf | 3 |
83 | mercaptoacetaldehyde | 1 |
84 | microbialites | 3 |
85 | microcavitations | 1 |
86 | myosin-polysaccharide | 1 |
87 | nanogels | 14 |
88 | ns4b | 6 |
89 | parameters/activation | 1 |
90 | pgf1alpha | 9 |
91 | phagocytosis/oxidative | 1 |
92 | phosphorelays | 2 |
93 | phosphorylation/dephosphorylation | 2 |
94 | poly-chains | 1 |
95 | rainier | 2 |
96 | rmdsod2 | 3 |
97 | rosettes | 6 |
98 | rotamer | 7 |
99 | royally | 1 |
100 | self-assemblies | 7 |
101 | self-oscillation | 6 |
102 | st-eepscs | 3 |
103 | steadiness | 40 |
104 | symmetries | 17 |
105 | symmetry | 572 |
106 | ta-vacancy | 1 |
107 | tb16.3-echa1 | 5 |
108 | triacetyl-d-mannosan | 1 |
109 | trialtypes | 1 |
110 | urinocoltures | 1 |
111 | v1-ige | 1 |
112 | á-granule | 1 |
113 | β-1,3-xylobiose | 1 |
1 | condi- | 1 |
2 | aggregation- | 1 |
3 | tb16.3-echa1 | 5 |
4 | d4-2 | 1 |
5 | 6,284,262 | 1 |
6 | rmdsod2 | 3 |
7 | bicep2 | 1 |
8 | k5fluo-3 | 1 |
9 | his6-mm1854 | 1 |
10 | gp5 | 8 |
11 | at-076 | 4 |
12 | acam2017 | 1 |
13 | dp47 | 1 |
14 | pgf1alpha | 9 |
15 | activation/thrombocytopenia | 1 |
16 | angiopep-peg-pla | 3 |
17 | 143-3beta | 1 |
18 | ns4b | 6 |
19 | gplb | 6 |
20 | glycogenic | 3 |
21 | elastase-generated | 1 |
22 | h-bond | 39 |
23 | function.evidence | 1 |
24 | myosin-polysaccharide | 1 |
25 | mercaptoacetaldehyde | 1 |
26 | v1-ige | 1 |
27 | diet.the | 2 |
28 | fat/muscle | 1 |
29 | á-granule | 1 |
30 | hydroxycyclopentadiene | 1 |
31 | 3-chloro-5-nitrotyrosine | 1 |
32 | 3-acetyl-4-hydroxy-6-alkyl-α-pyrone | 2 |
33 | 3-acetyl-4-hydroxy-6-propyl-α-pyrone | 1 |
34 | 12-lipoxygenase | 9 |
35 | elastase | 253 |
36 | β-1,3-xylobiose | 1 |
37 | 2,4,6-trihydroxymandelate | 1 |
38 | phagocytosis/oxidative | 1 |
39 | macrophage-csf | 3 |
40 | 15g | 6 |
41 | cross-matching | 17 |
42 | gating | 351 |
43 | aggregation-inhibiting | 1 |
44 | glycal | 2 |
45 | azurophil | 1 |
46 | cd4ol | 1 |
47 | chlorophenol | 5 |
48 | 198,000/µl | 1 |
49 | isolate-dextran | 1 |
50 | triacetyl-d-mannosan | 1 |
51 | aureolysin | 1 |
52 | aggregation | 2,774 |
53 | deaggregation | 1 |
54 | self-oscillation | 6 |
55 | phosphorylation/dephosphorylation | 2 |
56 | hyperphosphorylation | 72 |
57 | co-ordination | 51 |
58 | coordination | 1,558 |
59 | incoordination | 32 |
60 | demargination | 1 |
61 | copigmentation | 6 |
62 | adhesion/activation | 1 |
63 | aggregation/activation | 1 |
64 | parameters/activation | 1 |
65 | cocontraction | 23 |
66 | activity/function | 2 |
67 | h2map | 1 |
68 | rainier | 2 |
69 | rotamer | 7 |
70 | l1-solver | 1 |
71 | st-eepscs | 3 |
72 | coherencies | 1 |
73 | self-assemblies | 7 |
74 | symmetries | 17 |
75 | jealousies | 1 |
76 | dihydropyrazinones | 1 |
77 | trialtypes | 1 |
78 | urinocoltures | 1 |
79 | aggregates | 793 |
80 | microbialites | 3 |
81 | amastigotes | 42 |
82 | rosettes | 6 |
83 | hysteresis | 146 |
84 | homozygosis | 7 |
85 | 'paralysis | 1 |
86 | hemiacetals | 1 |
87 | nanogels | 14 |
88 | 2,3-disubstituted-cis-2,3-dihydrobenzofurans | 1 |
89 | poly-chains | 1 |
90 | microcavitations | 1 |
91 | clumps | 16 |
92 | homodimers | 32 |
93 | heterotrimers | 2 |
94 | adp-receptors | 1 |
95 | steadiness | 40 |
96 | anti-aggregants | 2 |
97 | antiaggregants | 4 |
98 | engrafments | 1 |
99 | phosphorelays | 2 |
100 | aqueduct | 34 |
101 | engraftment | 219 |
102 | footprint | 94 |
103 | abi/pwv | 1 |
104 | gaasxsb1-x | 1 |
105 | ta-vacancy | 1 |
106 | royally | 1 |
107 | symmetry | 572 |
108 | asymmetry | 555 |
109 | aggregability | 47 |
110 | hyper-aggregability | 6 |
111 | hyperaggregability | 4 |
112 | activatability | 1 |
113 | activability | 1 |